To guide public health and vaccination strategies, researchers assessed a variety of factors regarding community-acquired pneumonia and its causes.
|Slideshows|September 20, 2019
At a Glance: Asthma Biologics
Author(s)Rachael Zimlich, RN, BSN
Advertisement
As featured in Asthma Care Complications from our September issue. Swipe through the images for product descriptions and links to prescribing information.Â
Advertisement
Related to this article
A new option for adults who have experienced stroke will now be available to further reduce future risk.
Investigators believe triglyceride testing could improve viral sepsis risk more broadly based on study findings.
Nicholas Rebold, PharmD, MPH, BCIDP, AAHIVP, explains how education eases inpatient switches, and how the protocol cuts costs and simplifies workflow.
Findings from a meta-analysis of over 125 clinical trials led the agency to require a class-wide label change.
Gilead’s current lenacapavir patent is what makes Dr Reddy’s Laboratories’ formulation tentative.
Mark Ey, RPh, from NCPA, joins to discuss the opportunities for independent pharmacies within the ACCESS to Pharmacy Care Program.
Researchers say this net loss is unlikely to reverse without state and federal policy changes, including PBM reform.
Advertisement
Advertisement
Trending on Drug Topics
1
High Triglycerides Independently Linked with Severe COVID-19 Death
2
FDA Adds NAION Eye Risk Warning to All GLP-1 Labels
3
US Lost Over 3000 Pharmacies From 2022 to 2024, Mostly Chains
4
FDA Approves Asundexian, First FXIa Inhibitor for Stroke Prevention
5